Hepion Pharmaceuticals

NASH on the Cusp: An Emerging Market Opportunity
BioSpace
Mon, 10/23/23 - 09:53 am
NASH
Viking Therapeutics
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Akero Therapeutics
Hepion Pharmaceuticals
Novo Nordisk
Galmed Pharmaceuticals
Hepion Claims Phase II NASH Victory Following Intercept’s Adcomm Defeat
BioSpace
Mon, 05/22/23 - 10:01 pm
Hepion Pharmaceuticals
clinical trials
NASH
rencofilstat
Hepion screens first subject in Phase IIb trial of NASH drug
Clinical Trials Arena
Thu, 09/1/22 - 10:42 am
Hepion Pharmaceuticals
NASH
clinical trials
rencofilstat